Apollo PrefA APOA Stock Is It Gaining Market Strength Invesco CurrencyShares Japanese Yen Trust FXY Rallies Amid Broad US Dollar Weakness And Intervention Speculation Outlook Therapeutics OTLK Stock Is It Worth Allocating Capital Q1 2026 Profit Disappoints What is driving sentiment for Opendoor OPENL stock VSTM Verastem quarterly report shows zero revenue but management highlights clinical trial progress and upcoming milestones MU Q1 2026 Earnings Strong EPS Surprise but Stock Declines Peraso Inc PRSO Q1 2026 Earnings Narrower Revenue Disclosure as EPS Misses Estimates AEE Q1 2026 Earnings EPS Beats Estimates as Operational Strength Drives Performance BEKE Q1 2026 Earnings EPS Misses Estimates as Housing Market Headwinds Persist WPC Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Decline Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline